Clinical efficacy and safety of percutaneous transhepatic portal embolization (PTPE) with N-butyl 2-cyanoacrylate-lipiodol-ethanol (NLE) before liver resectio
Not Applicable
- Conditions
- hepatocellular carcinoma,intrahepatic cholangiocarcinoma,metastatic liver tumor
- Registration Number
- JPRN-UMIN000024103
- Lead Sponsor
- Wakayama medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1) Ascites 2) Patients with a bleeding tendency(Plt: less than 50,000/mm3, PT-INR: more than 1.5) 3) poor renal function(eGFR: less than 30 ml/min/1.73m2)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Procedure-related complications
- Secondary Outcome Measures
Name Time Method Adverse event,increase rate of residual liver volume ,changes in liver function before and after the PTPE, the portal vein recanalization